Filter
14
Text search:
vector-based
vaccine
Featured
New Publications
1
Language
Document type
Guidelines
5
Studies & Reports
2
Videos
2
No document type
2
Training Material
1
Brochures
1
Fact sheets
1
Countries / Regions
Germany
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
3
Clinical Guidelines
1
Toolboxes
COVID-19
9
Ebola & Marburg
2
Refugee
1
Zika
1
TB
1
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
The Committee examined the clinical development of Ebola virus vaccines and conducted an inventory of available data on their safety. It also reviewed 3 generic issues: updating a global strategy on vaccine saf
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the b
...
AstraZeneca-SKBio in South Korea and Serum Institute of India
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of
...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Der BAGSO-Ratgeber informiert kompakt und verständlich zu Impfungen für Erwachsene ab 60 Jahren. Er gibt Antworten auf zwölf häufig gestellte Fragen, u.a. für wen welche Impfungen besonders wichtig sind, wo man sich beraten lassen kann und ob die Kosten von der Krankenkasse übernommen werden.
...
interim guidance, 19 July 2021 (arabic version)
2nd edition, June 2021
29 Dec 2021. Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
Orientations provisoires 19 juillet 2021
Available in English, German, French and Italian
Learn about the composition and delivery mechanism for the new classes of COVID-19 vaccines based on adenovirus from Johnson & Johnson and AstraZeneca with Dr. Jonathan Genzen, COO of ARUP Laboratories and an Associate Professor at the University of Utah School of Medicine.
